扫描下面的二维码:
"现场快报"标签列表
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(4)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(2)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(3)2007-11-14
TRB3 IS ASSOCIATED WITH HEPATIC LIPOGENESIS AND DYSLIPIDEMIA IN(1)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(4)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(3)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(1)2007-11-14
Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Non-Alcoholic(2)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (5)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (4)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (3)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (2)2007-11-14
Novel Therapeutic Approach for Nonalcoholic Fatty Liver Disease (NAFLD) using Antiplatelet (1)2007-11-14
THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(4)2007-11-14
THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(2)2007-11-14
THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(3)2007-11-14
THE EFFECT OF COMPLETE AND PARTIAL RESPONSE AT WEEK 12 ON SUSTAINED VIROLOGIC RESPONSE(1)2007-11-14
U.S. MULTICENTER PILOT STUDY OF DAILY CONSENSUS INTERFERON (INFERGEN) PLUS RIBAVIRIN FOR (1)2007-11-14
U.S. MULTICENTER PILOT STUDY OF DAILY CONSENSUS INTERFERON (INFERGEN) PLUS RIBAVIRIN FOR (2)2007-11-14
Outcomes in HIV-HCV co-infected genotype 1 patients treated with peginterferon lafa-2a (40KD) (2)2007-11-14